NEW PODCAST: #PBS Update August 2026 @craigunderhill.bsky.social + Rachael Babin discuss #vorasidenib, #selpercatinib and #tafasitamab. Shout out to Jim Whittle, Katy Peters & #ArchieGoodwyn #glioma #lymphoma #thyroidcancer #IDH @dukecancer.bsky.social @petermaccc.bsky.social Listen now: t.ly/jkDnJ

NEW OJC🎙️Negative trials matter We explore PERISCOPE II, NeoSUMMIT-01 and whether it's time to rethink the traditional curative vs palliative framework in modern oncology | Listen: t.ly/g5RAT #Oncology #Podcast #MedEd #OncologyJournalClub #Cancer #CanSky #MedSky #OncSky @craigunderhill.bsky.social

Login / Sign Up – The Oncology Network

Free access for registered Healthcare Professionals.

t.ly

🎧 NEW PODCAST | How do you manage the unique toxicities associated with FGFR inhibitors in #iCCA? Join A/Prof Jenny Liu + Prof John Bridgewater as they discuss: ✔️ Early molecular testing ✔️ Hyperphosphataemia & mucositis ✔️ Nail, skin & eye toxicities ✔️ And much more... Listen now: t.ly/kjU3b

🎧 NEW PODCAST | TRANSFORMING iCCA In Episode 1, Prof Nick Pavlakis and Prof John Bridgewater explore how molecular profiling and targeted therapies are reshaping the management of intrahepatic cholangiocarcinoma. 🎧 Listen now: t.ly/bEvfI #iCCA #Cholangiocarcinoma #PrecisionOncology #MedEd

🎙️ PODCAST- The PBS Update | Prof @craigunderhill.bsky.social + guest Prof John Zalcberg AO discuss the growing challenges facing Australia's #PBS, delays accessing cancer medicines and what reforms may be needed | Listen here: t.ly/wIMvb + Apple, Spotify etc #OncologyPodcast #CanSky #MedSky #OncSky

Read the highlights from the IGNITE Educational Meeting on Immunotherapy and the Evolving Management of Nasopharyngeal Carcinoma | Read here: t.ly/UXOV9 #NasopharyngealCarcinoma #DrReddys #DannyRischin #OncologyNews #IndustrySpotlight #MedEd #Heath #CancerResearch #MedSky #CanSky #OncSky

How do treatment decisions evolve for patients with BRAF-mutant melanoma in the immunotherapy era? Listen to the experts! Prof Victoria Atkinson and A/Prof Matteo Carlino share pearls of wisdom in these short form podcast mini-episodes: t.ly/XxivC #OncologyPodcast #MedEd #Melanoma #BRAF #PierreFabre

The Oncology Journal Club Podcast's Bingo is back 🎙️Listen to our ASCO Special Episode Part 2 now! @craigunderhill.bsky.social's love of Qantas PJs has officially earned a place on this year's bingo card 😂 How many mentions can you count? Listen here: t.ly/pHSXR #OncologyPodcast #OJC #MedEd #ASCO2026

🎲 #ASCO Bingo is back! How many phrases can you tick off as you listen to the funniest oncology educational podcast around? The #OJC dive into the plenary studies from #ASCO2026 in Part 1: t.ly/V_SqO #Oncology #CanSky #OncSky #OncologyPodcast @ascocancer.bsky.social @craigunderhill.bsky.social

It's #WorldProstateCancerDay so the perfect time to pop in your ear buds and listen to Dr Niara Oliveira and Dr Vivek Rathi busting some BRCA testing myths! Listen here: t.ly/s-RDf #BRCA #ProstateCancer #Oncology #OncologyPodcast #MedEd #Pathology #MedicalOncology #CanSky #MedSky #OncSky

NEW PODCAST🎙️In Part 1 of our ASCO special, the Oncology Journal Club team review the plenaries. Join @craigunderhill.bsky.social, Christopher Jackson + Kate Clarke to discuss the evidence behind the headlines. Listen now: t.ly/YOc4V P.S. be prepared for karaoke! #ASCO2026 @ascocancer.bsky.social

NEW ONCOLOGY JOURNAL CLUB PODCAST! From RAS(ON) results which our resident sceptic called 'mouthwatering' through to Bob Marley's melanoma: t.ly/c2JYo Thanks to @craigunderhill.bsky.social, Chris Jackson + Kate Clarke #OJC #OncologyPodcast #MedEd #CancerResearch #MedSky #CanSky #OncoSky

“Scientific breakthroughs mean little if health systems cannot operationalise them.” Cellular therapies are moving beyond blood cancers. We cover a new paper in npj Precision Oncology highlighting why institutional readiness is just as important as scientific breakthroughs | t.ly/VvUPp

NEW PODCAST: A new #PBS listing can change a treatment plan overnight. We break down the May 2026 oncology and haematology updates in this quick episode. Thanks to @craigunderhill.bsky.social for insightful analysis as always! t.ly/AXa9e #fruquintinib #epcoritamab #CART #myeloma

New PBS listing for third-line or later treatment of mCRC patients | Read more here... t.ly/5n391 #HCPs #PBS #PBSUpdate #mCRC #ColorectalCancer #GICancers #MedicalOncology

Early molecular testing is changing what’s possible in cholangiocarcinoma🎙️ New episode: The Case for Early Molecular Testing HCPs can listen now 👇t.ly/RZWKz #Oncology #Cholangiocarcinoma #PrecisionMedicine #IDH1 #TACE #SIRT #InterventionalRadiology #GICancer

Listening material for the weekend? Check out the latest episode of The Oncology Journal Club - perfect listening for healthcare professionals working in cancer care: Listen: t.ly/K8HIc | Thanks to @craigunderhill.bsky.social for insightful analysis and leading the hosting team (herding cats? 🤣)

NEW OJC PODCAST 🎧 #iCCA, #genomic matching + #chronooncology Promising signals—but what actually changes practice? Thanks to @craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson | Listen: t.ly/a_hTM #Oncology #MedSky # OncSky MedEd #CancerResearch #CME #OncologyJournalClubPodcast

NEW PODCAST: Want a practical #PBS recap of all the crucial updates for Australian oncology practice? Hit play on The PBS Update April 2026! Thanks to @craigunderhill.bsky.social for sharing his insights with us | Listen: t.ly/E_y9F + Spotify etc #PBSUpdate #Oncology #Cancer #Haematology #RareCancer

Cholangiocarcinoma is often diagnosed late — but 40–50% of patients may have actionable mutations In our latest podcast, we explore the case for early molecular testing and the role of the MDT in expanding treatment options | 🎧 Listen: t.ly/J_Wv2 #oncology #MedEd #BTC #BillaryTractCancers #OncSky

🎧 Season 4 starts now 🎧 The Oncology Journal Club Podcast is back! With the same thoughtful analysis from @craigunderhill.bsky.social, Dr Kate Clarke + Prof Christopher Jackson. Ep 1 is a big one! Hot Flushes, Aspirin + AI. 🎧 Listen now > t.ly/amo1W #OJC #CancerResearch #OncologyPodcast #MedEd

ONCOLOGY NEWS: Could household cats hold the key to understanding breast cancer? Read the story here: t.ly/F3aqV #Cat #BreastCancer #CancerResearch #OncologyResearch #BreastResearch

ONCOLOGY NEWS: Updated PATINA Trial Results - catch-up with a quick Clinical Summary here: t.ly/uvjhe #PATINA #Palbociclib #HER2+MBC #metastaticbreastcancer

ONCOLOGY NEWS: Can AI improve the accuracy of identifying patients eligible for oncology clinical trials? Explore new research: t.ly/Jo5N3 #AI #ArtificalIntelligence #OncologyResearch #OncologyClinicalTrials #CancerTrials #CancerResearch #TrialParticipantSelection

Not just 'what' treatment, but 'when'? The emerging role of chrono-oncology: t.ly/lukx2 Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC #LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky

Intriguing new research: Triple-targeted therapy shows unprecedented efficacy in early pancreatic cancer models. Read here: t.ly/kTeMr #PDAC #KRAS #STAT3 #EGFR #OncologyNews #OncologyNetworkAustralia #Spain #CNIO #OncSky #MedSky #CanSky

Login / Sign Up – The Oncology Network

Free access for registered Healthcare Professionals.

t.ly

PBS listing announced for treatment of unresectable or metastatic, well-differentiated extra-pancreatic or pancreatic neuroendocrine tumours | Read here: t.ly/XEO16 #pancreaticcancer #pancreaticNETs #NETs

PBS Update: ZYTORVI™ (toripalimab) is the first and only PBS reimbursed immunotherapy for eligible patients with recurrent locally advanced/metastatic nasopharyngeal carcinoma (R/M NPC). Read more here: t.ly/OyAd4

Ho ho ho! It's our favourite time of year - the #OJC End of Year Special Podcast has dropped! Thanks to @craigunderhill.bsky.social, Kate Clarke + Christopher Jackson for their hard work keeping our brains tickled this year: t.ly/oAto7 #OncologyJournalClubPodcast #OncologyPodcast

🎙️ New episode: HER2 Uncovered – From Low to Ultralow A/Prof Ben Dessauvagie & Prof Gelareh Farshid explore HER2 ultralow breast cancer, evolving pathology practice and implications for MDT decision-making. 🎧 Listen now: t.ly/3E4kJ | #BeyondtheSlide #HER2 #HER2Ultralow #Oncology#MedEd #BreastCancer